dr-john-campbell 2 months ago
retired nurse teacher #Health

Ivermectin and Mebendazole, 84% Benefit in Cancer

In this prospective real-world cohort, the combination of ivermectin and mebendazole was associated with high rates of self-reported clinical benefit, with nearly half of participants reporting tumours regression or no current evidence of disease across a heterogeneous population of cancer patients.

Dr. John Campbell
retired nurse teacher